Medical Digest & Congress Report

Prof. Michiel Rienstra discusses the practical implementation of the ESC Atrial Fibrillation Guidelines at the ESC Congress 2026, offering actionable strategies to streamline clinical workflows and optimize patient care.

Video: https://medicaldigest.org/scientific-contents/interview:practical-implementation-esc-atrial-fibrillation-guideline

Prof. Marianna Adamo outlines the updated 2026 ESC Guidelines for the Management of Heart Failure at the ESC Congress 2026, highlighting essential advances in diagnosis, early therapy initiation, and disease management.

Video: https://medicaldigest.org/scientific-contents/interview:2026-esc-guidelines-management-heart-failure

Prof. Elmir Omerovic presents key results from the SWITCH SWEDEHEART trial at the ESC Congress 2026, evaluating the safety and efficacy of switching from ticagrelor to prasugrel in patients with acute coronary syndromes.

Video: https://medicaldigest.org/scientific-contents/interview:switch-swedeheart-switching-ticagrelor-prasugrel-acs

Prof. Piotr Ponikowski discusses the critical gap between heart failure guidelines and real-world clinical practice, exploring the missing pieces needed for successful guideline-directed medical therapy (GDMT) implementation.

Video: https://medicaldigest.org/scientific-contents/interview:guidelines-clinical-impact-key-takeaways-gdmt-implementation-report-esc-2026

Prof. Shelley Zieroth addresses the critical importance of early, in-hospital initiation of guideline-directed medical therapy for heart failure at the ESC Congress 2026, highlighting practical strategies to improve patient outcomes during post-discharge transition.

Video: https://medicaldigest.org/scientific-contents/interview:start-early-start-hospital-translating-heart-failure-guidelines-practice

Prof. Felix Mahfoud summarizes the main highlights and key clinical takeaways from the ESC Congress 2026, showcasing practice-changing trial results, new guidelines, and breakthroughs across AI, cardiometabolic disease, and interventional cardiology.

Video: https://medicaldigest.org/scientific-contents/interview:main-highlights-and-key-clinical-takeaways-esc-2026

Prof. Giuseppe Rosano addresses key challenges in implementing guideline-directed medical therapy at the ESC Congress 2026, exploring strategies to bridge the gap between clinical recommendations and real-world cardiovascular care.

Video: https://medicaldigest.org/scientific-contents/interview:guidelines-clinical-impact-gdmt-implementation

Prof. Boyoung Joung presents findings from the landmark SINGLE-AF trial at the ESC Congress 2026. The study demonstrates that direct oral anticoagulants (DOACs) significantly reduce stroke risk in atrial fibrillation patients at intermediate risk without increasing major bleeding.

Video: https://medicaldigest.org/scientific-contents/interview:single-af-anticoagulation-atrial-fibrillation-intermediate-stroke-risk

Prof. Ashkan Shoamanesh presents key findings from the ENRICH-AF trial at the ESC Congress 2026. The study evaluates whether edoxaban safely reduces stroke risk in high-risk atrial fibrillation patients with a history of intracranial hemorrhage, highlighting crucial trade-offs between ischemic stroke prevention and major bleeding risks.

Video: https://medicaldigest.org/scientific-contents/interview:enrich-af-edoxaban-intracranial-hemorrhage-survivors-atrial-fibrillation

Prof. Kristin Newby breaks down the new 5th Universal Definition of Myocardial Infarction at the ESC Congress 2026, highlighting refined diagnostic criteria and global clinical consensus.

Video: https://medicaldigest.org/scientific-contents/interview:5th-universal-definition-myocardial-infarction